Can You Switch From Wegovy to Mounjaro: Understanding Your Options
When patients ask whether they can switch from Wegovy to Mounjaro, the answer involves careful clinical consideration of both treatments' mechanisms and your individual response. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors for dual-hormone appetite regulation. Both are prescription-only medicines requiring clinical assessment, but they work through different pathways in your body's weight management systems. The decision to switch typically involves evaluating your current progress, any side effects experienced, and clinical factors that may favour one mechanism over another.
At EverydayMeds, both options are available through our GPhC-registered service (#9012878), allowing your prescriber to recommend the most suitable treatment based on your medical history and goals. Our clinical team regularly assists patients who are considering whether they can switch from Wegovy to Mounjaro, ensuring continuity of care throughout any transition. The assessment process remains consistent regardless of which treatment you're considering, with the same rigorous clinical standards applied to both prescribing decisions.
UK Pricing Comparison: Lowest Costs for Both Treatments
Understanding the financial commitment when you switch from Wegovy to Mounjaro requires transparent pricing comparison across both treatment options. Our Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the maintenance 2.4mg dose. These prices include clinical assessment, prescriber review, and next-day cold-chain delivery, representing exceptional value in the UK market. New customers apply discount code FIRST40 at checkout, whilst returning patients use DOSE25 to access these competitive rates.
When evaluating whether you can switch from Wegovy to Mounjaro, cost considerations extend beyond individual pen prices to include dosing schedules and titration periods. Our bundle options provide additional convenience, such as the Intro Trio (0.25mg, 0.5mg, and 1mg) for £299.99, covering your initial 12 weeks of treatment with Reliable Supply continuity. Both treatments require similar dose escalation approaches, though the specific titration schedules differ, making direct cost comparison dependent on your prescribed regimen and maintenance dose requirements.
Clinical Evidence: When Patients Switch From Wegovy to Mounjaro
The clinical rationale for switching from Wegovy to Mounjaro often centres on the dual-hormone mechanism that tirzepatide provides through both GIP and GLP-1 receptor activation. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved average weight loss of approximately 15% at 68 weeks (Wilding et al., NEJM, 2021). Mounjaro's SURMOUNT trials demonstrated its own efficacy profile through the dual incretin approach, though direct head-to-head comparisons require careful interpretation due to different trial designs and patient populations.
Clinical factors that may influence whether you can switch from Wegovy to Mounjaro include your response to single-hormone therapy, tolerability considerations, and individual metabolic factors. Both treatments work alongside a reduced-calorie diet and increased physical activity, but the additional GIP receptor targeting in Mounjaro may offer different appetite and satiety effects for some patients. Your prescriber will evaluate these factors during consultation, ensuring any treatment transition aligns with your clinical progress and weight management goals.
How Wegovy Works: GLP-1 Mechanism Before Switching
Before deciding whether you can switch from Wegovy to Mounjaro, understanding Wegovy's established mechanism helps inform your treatment decision. Semaglutide operates as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a natural hormone released when you eat. This hormone activation reduces appetite by working on brain appetite centres, particularly in the hypothalamus, whilst also promoting feelings of fullness after smaller meals. The treatment may reduce food cravings and slow gastric emptying, creating a natural reduction in calorie intake when combined with lifestyle modifications. Weekly injections maintain consistent therapeutic levels, providing sustained appetite regulation throughout your treatment period.
Streamlined Ordering Process for Both Treatment Options
Whether you're continuing with Wegovy or exploring switching to Mounjaro, our ordering process remains consistently efficient and clinically rigorous. The journey begins with a comprehensive 3-minute online clinical assessment, covering your medical history, current medications, weight management goals, and any previous experience with GLP-1 treatments. Following submission, your assessment undergoes prescriber review within our standard 3 working days timeframe, or 24 hours with our express service option. Once approved, your prescription-only medicine is prepared for next-day delivery using specialist cold-chain transport, maintaining the required 2-8°C temperature throughout transit. This streamlined approach ensures minimal delay when you're ready to begin or switch treatments, with full clinical oversight maintained throughout the process.
Storage and Practical Considerations When You Switch
Practical storage requirements represent an important factor when evaluating whether you can switch from Wegovy to Mounjaro, as both treatments have specific temperature maintenance needs. Wegovy requires refrigeration at 2-8°C before first use, but offers exceptional travel flexibility with up to 6 weeks stability at room temperature below 30°C once removed from the fridge. This storage advantage compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy particularly suitable for patients with frequent travel or variable storage access. Both treatments use pre-filled injection pens with similar administration techniques, though the specific dose escalation schedules differ between semaglutide and tirzepatide protocols. The FlexTouch pen system for Wegovy provides intuitive dose selection and injection, with clear visual confirmation of dose delivery.
Cost-Effective Treatment Switching: Maximising Your Investment
The financial strategy around switching from Wegovy to Mounjaro involves understanding both the immediate transition costs and long-term treatment investment. Unlike many competing services that obscure pricing with complex fee structures, EverydayMeds provides transparent, all-inclusive pricing that covers clinical assessment, prescriber consultation, prescription costs, and cold-chain delivery. This approach eliminates unexpected charges during treatment transitions, allowing accurate budgeting whether you continue with Wegovy or explore Mounjaro's dual-hormone approach.
Our pricing structure reflects genuine UK market leadership, particularly when considering the comprehensive service package included with each prescription. Many patients find that the clinical guidance provided during treatment switches justifies the investment, as proper medical oversight ensures optimal outcomes while minimising trial-and-error approaches. The discount codes FIRST40 and DOSE25 apply to both treatment options, ensuring consistent value regardless of your final prescriber recommendation.
Expert Clinical Support: Making the Right Switch Decision
The decision process around whether you can switch from Wegovy to Mounjaro benefits significantly from expert clinical input, as both treatments require careful medical oversight and individualised approaches. Our prescribers regularly evaluate patients considering treatment switches, assessing factors including current weight loss progress, side effect profiles, lifestyle considerations, and clinical indicators that may favour one mechanism over another. This expertise proves invaluable in navigating the complexities of prescription weight management, ensuring your treatment choice aligns with both clinical best practice and personal circumstances. Ready to explore your options with the UK's lowest prices and expert clinical support? Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment, applying code FIRST40 for new customers or DOSE25 for returning patients at checkout, and discover why thousands choose EverydayMeds for their prescription weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026